Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma

2019737 citationsJournal Articlebronze Open Access

Authors

ClinicalTrials.gov identifier: NCT02558894.

Good health and well-being

Published in: JAMA Oncology

Volume 5, Issue 10, pp. 1431-1431

Field-Weighted Citation Impact: 32.34